3Andriulli A, Clemente R, Solmi L, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis A multicenter, placebo-controlled, randomized clinical trial[J]. Gastroenterol Endoscopy, 2002, 56: 488.
4Prat F, Amaris J, Ducot B, et al. Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study[J]. Gastrointest Endosc, 2002, 56: 202.
5Gottlieb K, Sherman S. ERCP and biliary endoscopic sphincterotomy-induced pancreatitis[J]. Gastrointest Endosc Clin N Am, 1998, 8: 87.
6Raty S, Sand J, Pulkkinen M, et al. Post-ERCP pancreatitis: reduction by routine antibiotics[J]. J Gastrointest Surg, 2001, 5: 339.
7Fogel E L, Eversman D, Jamidar P, et al. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone[J]. Endoscopy, 2002, 34: 280.
8Moreto M, Zaballa M, Casado I, et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial[J]. Gastrointest Endosc, 2003, 57: 1.
9Arvanitidis D, Anagnostopoulos G K, Giannopoulos D, et al. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial[J]. J Gastroenterol Hepatol, 2004, 19: 278.
10Barthet M , Desjeux A , Gasmi M . Early refeeding after endoscopic biliary or pancreatic sphincterotomy: A Randomized Prospective Study . Endoscopy,2002,34(7) :546 ～ 550.
